MDRM – Set To Acquire First Of Its Kind Disease Detection Equipment!

StocksGoneWild.Com Newsletter

If you are having trouble viewing this message, please go to http://community.icontact.com/p/stocksgonewild/newsletters/sgw/posts/mdrm-set-to-acquire-first-of-its-kind-disease-detection-equipment [1] [2] [3] [4] RECENT WINNERS: YBTVQ: +4233% SCNG: +660% STHG: +1100% WSRA: +700% THE NEW WILD PICK IS…[5]MDRM (Modern Mobility Aids) Good Morning Fellow Traders, The market plunged yesterday. The [6]DOW shed 248 points erasing over a month worth of gains. Over here at SGW, this November alone we have seen 378% gains with only a few well timed alerts.

Our latest alert, [7]MDRM – Modern Mobility Aids, which ended yesterday`s trading at 0.11 has bottom bounce potential. [8]MDRM acquires and partners with companies that are in the early stage Pharma businesses and targets research and development in the health sector. [9]MDRM recently completed due diligence on a company which has the FIRST EVER TECHNOLOGY OF ITS KIND! [10]MDRM just recently [11]announced that they expect to close on a company called Lumigene Technologies Inc. This company is the first of its kind to have developed a test that would return within an hour the detection of pathogens, infectious diseases and other ailments in a person.

In fact, the far reaching applications of this type of technology does not only allow for hospital or clinic setting satisfaction, it can even be applied in airport settings where speed is of utmost necessity.

The best part about this product is the ease with which it can be used. One doesn`t need a complex laboratory setting, or even specially trained physicians. It is a device that is portable, can be battery operated, and is built around an easy to use color touch screen interface.

The need for speed in identifying infectious human diseases is getting more and more necessary, and the test that LumiGene has developed is in an industry that is one of the most attractive in this sector.

Here are a [12]few facts about the Molecular Diagnostics industry:

Revenues from worldwide sales expect to grow by more than 11% annually 60% of the entire revenues are for detection of infectious diseases – the precise industry LumiGene has focused on! Approximately 600 hospital laboratories and 200 independent laboratories perform high-volume testing that necessitates both automated molecular diagnostic testing platforms and systems that simplify and accelerate sample preparation By 2014, worldwide revenue expects to reach $6.2 billion The bio pharma sector is well heeled and very well known for its overnight surges. If a drug gets approved or a product screened for success, its stock can literally double, triple and much more overnight. Some recent examples of these are REGN, PCRX, and INCY that saw overnight boosts because of FDA approval.

The global potential for this rapid response test is far reaching and [13]LumiGene doesn`t intend to stop with detecting human diseases. They expect to commercialize their technology even further to include:

Veterinary Food Safety Testing Environmental Monitoring Biothreat Monitoring The top nine giants that control over 75% of the molecular diagnostics market have combined values of trillions of dollars, and the undisputed market leader with almost 30% share and an unparalleled product portfolio, which includes molecular diagnostic tests for oncology, virology, microbiology, and blood screening is Roche Diagnostics.

When Roche [14]decided to buy out another company, Ventana, because it wanted to develop and broaden its molecular diagnostic offerings, Ventana`s price shot up over 72% from prior to Roche`s offer.

Any one of the nine giants in the industry could take note of LumiGene`s technology. With such strong potential developments and a price of 0.11, the momentum and volume of [15]MDRM has begun to see some serious increases. The bottom bounce potential of [16]MDRM is all too imminent and with the FIRST PRODUCT OF ITS KIND ever to reach the market the widespread potential of LumiGene is all too evident to the keen observer.

Happy Trading! [17]Stocksgonewild.com Disclaimer: [18]http://www.stocksgonewild.com/disclaimer This email and the content provided is intended for commercial advertisement purposes only. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our e-mail list. PLEASE NOTE: Stocksgonewild.com employees are not registered as an Investment Advisor or Investment Analyst in any jurisdiction whatsoever. This is not an independent and unbiased newsletter. Full disclaimer can be read at [19]http://www.stocksgonewild.com/disclaimer. Release of Liability: Through use of this website/newsletter viewing or using you agree to hold Stocksgonewild.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Stocksgonewild.com`s affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. This may occur anytime before, during or after Stockgonewild`s advertisement efforts. Any opinions expressed are subject to change without notice. Stocksgonewild.com encourages readers and investors to supplement the information in these reports with independent research and other pro advice. All information on featured companies is provided by the companies profiled, through their website or is available from public sources and Stocksgonewild.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies.

Stockwgonewild.com does not independently investigate the information.

Stocksgonewild.com often receives compensation for marketing, awareness and investor relation services, which can be reviewed within our disclaimer. For mdrm we received forty thousand dollars by a third party, Jrz capital for a one day awareness program. Stocksgonewild.com does not own any shares of mdrm, incy, regn, or pcrx. The third party may have shares and may liquidate them which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. This is not a solicitation to buy or sell any securities. Any claims or Statements should be deemed apocryphal.

Stocksgonewild.com, nor any of its affiliates are registered investment advisors or broker dealers.

References 1. http://www.stocksgonewild.com/

2. http://www.stocksgonewild.com/contact 3. http://www.facebook.com/group.phpgid0044162369192&ref=ts 4. http://www.twitter.com/stocksgonewild 5. http://stockcharts.com/h-sc/uis=mdrm 6. http://stockcharts.com/h-sc/uis=%24INDU 7. http://stockcharts.com/h-sc/uis=mdrm 8. http://stockcharts.com/h-sc/uis=mdrm 9. http://stockcharts.com/h-sc/uis=mdrm 10. http://stockcharts.com/h-sc/uis=mdrm 11. http://finance.yahoo.com/news/Modern-Mobility-Aids-Inc-prnews-2859425538.htmlx=0&l=1 12. http://www.genengnews.com/gen-articles/infectious-disease-molecular-diagnostics/3918/

13. http://lumigene.myhosting.net/products/markets.html 14. http://www.roche.com/med-cor-2008-01-22 15. http://stockcharts.com/h-sc/uis=mdrm 16. http://stockcharts.com/h-sc/uis=mdrm 17. http://www.stocksgonewild.com/

18. http://www.stocksgonewild.com/disclaimer 19. http://www.stocksgonewild.com/disclaimer This message was sent to from:

I.C. USA Inc. | POB 230491 | Brooklyn, NY 11223

Related posts:

1. This Friday you will Bear Witness to the WILDEST Sub-Penny Pick!
2. AMEL Rushes Up 18% After Our Alert!
3. AAST Has One Of The Best Charts Of The Year!
4. Our Alerts This Month Rose 20%, 48%, 235%, & 36% + Mkt Update
5. FMYR is Our Low Float WILD New Immediate Alert